Transcriptomics

Dataset Information

0

Gene signature profiles in whole blood cells from severe asthma patinets treated with benralizumab


ABSTRACT: Severe asthma is a clinically and physiologically heterogeneous disease. Benralizumab is a monoclonal antibody which binds the alpha chain of the interleukin-5 receptor and used for severe eosinophilic asthma worldwide. However, not all eosinophilic asthma patients will benefit from benralizumab due to heterogeneity of this disease. Therefore, we performed comprehensive gene expression analysis of whole blood cells that examine severe asthma disease heterogeneity in response to benralizumab. This study is the first to perform comprehensive transcriptome analysis of whole blood cells to identify transcriptomic endotypes of severe asthma clusters that correlate with benralizumab response. The identified transcriptomic endotypes of severe asthma clusters are associated with gene signatures of eosinophils and neutrophilis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE148725 | GEO | 2023/04/15

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2014-04-07 | E-GEOD-56396 | biostudies-arrayexpress
2021-12-17 | E-MTAB-10190 | biostudies-arrayexpress
2021-07-31 | GSE143303 | GEO
2020-07-13 | GSE152004 | GEO
2019-06-30 | GSE123750 | GEO
2014-04-07 | GSE56396 | GEO
2016-12-09 | GSE69683 | GEO
2018-10-03 | GSE108417 | GEO
2015-12-10 | E-GEOD-65239 | biostudies-arrayexpress
2013-11-12 | E-GEOD-35571 | biostudies-arrayexpress